Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Human tumor stem cell assay]

K Inoue, M Arakawa, M Ogawa

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |April 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    The human tumor stem cell assay predicts chemotherapy response by evaluating anticancer drug effects on tumor cell colony formation. This in vitro method helps determine patient-specific chemosensitivity for better cancer treatment outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Ion channels on synaptic vesicle membranes studied by planar lipid bilayer method.

    Biophysical journal·1992
    Same author

    Extracellular matrix formation in piecemeal necrosis: immunoelectron microscopic study.

    Liver·1992
    Same author

    Roles of Ca2+ influx through ATP-activated channels in catecholamine release from pheochromocytoma PC12 cells.

    Journal of neurophysiology·1992
    Same author

    Establishment of a folliculo-stellate-like cell line from a murine thyrotropic pituitary tumor.

    Endocrinology·1992
    Same author

    An extract of Gymnema sylvestre leaves and purified gymnemic acid inhibits glucose-stimulated gastric inhibitory peptide secretion in rats.

    The Journal of nutrition·1992
    Same author

    [Selection of methods for diagnosis and treatment of pancreatic cancer].

    Gan to kagaku ryoho. Cancer & chemotherapy·1992
    Same journal

    [A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Recent Advances in the Treatment of HER2-Altered Solid Tumors].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [BRAF-Mutant Solid Tumor].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    See all related articles

    Area of Science:

    • Oncology
    • Cell Biology
    • Pharmacology

    Context:

    • Cancer patient tumors exhibit variable responses to chemotherapy.
    • Predicting individual patient response to anticancer agents is crucial for effective treatment.
    • In vitro assays offer a method to assess tumor cell chemosensitivity.

    Purpose:

    • To evaluate the utility of the human tumor stem cell assay (HTSCA) for predicting patient-specific chemotherapy response.
    • To assess the correlation between HTSCA results and clinical outcomes.
    • To establish HTSCA as a tool for personalized cancer therapy.

    Summary:

    • The human tumor stem cell assay is an in vitro technique using double soft agar layers to culture tumor cells and assess lethality via colony formation.
    • Tumor cells from cancer patients are exposed to anticancer agents, and antitumor effects are evaluated by the percentage of colony formation inhibition.

    Related Experiment Videos

  • The assay demonstrated successful colony formation in 74% of 57 tumor specimens, with varying rates across different cancer types (e.g., breast cancer 93%, lung cancer 25%).
  • High correlation between HTSCA results and patient response to chemotherapy has been reported, indicating its predictive value.

    • Impact:

    • The human tumor stem cell assay serves as a valuable tool for predicting chemotherapy sensitivity in individual cancer patients.
    • This assay can guide treatment decisions, potentially improving therapeutic efficacy and patient outcomes.
    • Facilitates personalized medicine approaches in oncology by enabling pre-treatment chemosensitivity testing.